22 research outputs found

    Breeding strategies and programmes

    Get PDF
    This section serves as an update of the overview of the state of the art in genetic improvement methods presented in the first report on The State of the World’s Animal Genetic Resources for Food and Agriculture (first SoW-AnGR) (FAO, 2007a).1 The importance of appropriate breeding strategies and programmes is highlighted throughout the Global Plan of Action for Animal Genetic Resources (FAO, 2007b), particularly in Strategic Priority Area 2, Sustainable Use and Development. The material presented in the first SoW-AnGR included an overview of the “context for genetic improvement”, which described both the factors influencing the objectives of breeding programmes (market demands, wider societal concerns about the nature and impacts of livestock production, the need to provide animals suitable for a diverse range of production environments, growing recognition of the importance of maintaining genetic diversity in livestock populations, etc.) and the latest scientific and technological developments in the field. This was followed by a description of the various activities or “elements” that make up a breeding programme and then by a review of the current state of breeding programmes by production system (high input vs. low input) and by species. Much of this material remains relevant. While the livestock sector is continuously evolving (see Part 2), the challenges that breeding programmes have to contend with remain broadly similar to those that existed at the time the first SoW-AnGR was prepared (2005/2006). Similarly, the basic constituent elements of a typical breeding programme have not changed

    Updating test-day milk yield factors for use in genetic evaluations and dairy production systems: a comprehensive review

    Get PDF
    Various methods have been proposed to estimate daily yield from partial yields, primarily to deal with unequal milking intervals. This paper offers an exhaustive review of daily milk yields, the foundation of lactation records. Seminal advancements in the late 20th century concentrated on two main adjustment metrics: additive additive correction factors (ACF) and multiplicative correction factors (MCF). An ACF model provides additive adjustments to two times AM or PM milk yield, which then becomes the estimated daily yields, whereas an MCF is a ratio of daily yield to the yield from a single milking. Recent studies highlight the potential of alternative approaches, such as exponential regression and other nonlinear models. Biologically, milk secretion rates are not linear throughout the entire milking interval, influenced by the internal mammary gland pressure. Consequently, nonlinear models are appealing for estimating daily milk yields as well. MCFs and ACFs are typically determined for discrete milking interval classes. Nonetheless, large discrete intervals can introduce systematic biases. A universal solution for deriving continuous correction factors has been proposed, ensuring reduced bias and enhanced daily milk yield estimation accuracy. When leveraging test-day milk yields for genetic evaluations in dairy cattle, two predominant statistical models are employed: lactation and test-day yield models. A lactation model capitalizes on the high heritability of total lactation yields, aligning closely with dairy producers’ needs because the total amount of milk production in a lactation directly determines farm revenue. However, a lactation yield model without harnessing all test-day records may ignore vital data about the shapes of lactation curves needed for informed breeding decisions. In contrast, a test-day model emphasizes individual test-day data, accommodating various intervals and recording plans and allowing the estimation of environmental effects on specific test days. In the United States, the patenting of test-day models in 1993 used to restrict the use of test-day models to regional and unofficial evaluations by the patent holders. Estimated test-day milk yields have been used as if they were accurate depictions of actual milk yields, neglecting possible estimation errors. Its potential consequences on subsequent genetic evaluations have not been sufficiently addressed. Moving forward, there are still numerous questions and challenges in this domain

    Mesenchymal stromal cells’ therapy for polyglutamine disorders: where do we stand and where should we go?

    Get PDF
    Polyglutamine (polyQ) diseases are a group of inherited neurodegenerative disorders caused by the expansion of the cytosine-adenine-guanine (CAG) repeat. This mutation encodes extended glutamine (Q) tract in the disease protein, resulting in the alteration of its conformation/physiological role and in the formation of toxic fragments/aggregates of the protein. This group of heterogeneous disorders shares common molecular mechanisms, which opens the possibility to develop a pan therapeutic approach. Vast efforts have been made to develop strategies to alleviate disease symptoms. Nonetheless, there is still no therapy that can cure or effectively delay disease progression of any of these disorders. Mesenchymal stromal cells (MSC) are promising tools for the treatment of polyQ disorders, promoting protection, tissue regeneration, and/or modulation of the immune system in animal models. Accordingly, data collected from clinical trials have so far demonstrated that transplantation of MSC is safe and delays the progression of some polyQ disorders for some time. However, to achieve sustained phenotypic amelioration in clinics, several treatments may be necessary. Therefore, efforts to develop new strategies to improve MSC's therapeutic outcomes have been emerging. In this review article, we discuss the current treatments and strategies used to reduce polyQ symptoms and major pre-clinical and clinical achievements obtained with MSC transplantation as well as remaining flaws that need to be overcome. The requirement to cross the blood-brain-barrier (BBB), together with a short rate of cell engraftment in the lesioned area and low survival of MSC in a pathophysiological context upon transplantation may contribute to the transient therapeutic effects. We also review methods like pre-conditioning or genetic engineering of MSC that can be used to increase MSC survival in vivo, cellular-free approaches-i.e., MSC-conditioned medium (CM) or MSC-derived extracellular vesicles (EVs) as a way of possibly replacing the use of MSC and methods required to standardize the potential of MSC/MSC-derived products. These are fundamental questions that need to be addressed to obtain maximum MSC performance in polyQ diseases and therefore increase clinical benefits.Portuguese Foundation for Science and Technology: SFRH/BD/148877/2019; CENTRO01-0145-FEDER-000008 CENTRO-01-0145FEDER-022095 POCI-01-0145-FEDER-016719 POCI-01-0145-FEDER-029716 POCI01-0145-FEDER-016807 POCI-01-0145-FEDER016390 UID4950/2020 CENTRO-01-0145-FEDER-022118info:eu-repo/semantics/publishedVersio

    Genetic and phenotypic studies on culling in Quebec Holstein cows

    No full text
    A series of studies were conducted to evaluate genetic and phenotypic aspects of culling, herd life and survival in Quebec Holstein herds. Data consisted of lactation records obtained from the Programme d'Analyse des Troupeaux Laitiers du Quebec (PATLQ) files, which included 2.2 Million records before the editing procedures. The average productive herd life in Quebec herds was approximately 33 months, corresponding to an average replacement rate of MIND, for both milk recording options. Herds enrolled in the PATLQ official option had cows with longer calving intervals and culled their heifers earlier than herds in the owner sampler option. The probability of being culled for each major reason for disposal was assessed by logistic regression models, and it was shown that culling for low production (voluntary) had a clearly descending trend from 1981 to 1994, while involuntary culling (assumed to include all the reasons other than production) increased in importance mainly because of the ascending trends observed for cuffing due to reproductive problems, mastitis and feet and legs problems. Proportion of cows culled for involuntary reasons increased with parity number, but the opposite occurred for culling due to low production. Herds in the official option culled less for mastitis and sold more cows for dairy purposes than owner sampler herds. After these preliminary studies, a sequence of Weibull models were fitted to analyze different aspects of the data. The genetic study of herd life traits focused on differences between sires regarding true and functional herd life, but also described the effect of different explanatory variables on the failure time variable. Heritability for true and functional herd life was, respectively, 0.09 and 0.08 in the log scale and 0.19 and 0.15 in the original scale. The difference in the median survival time of daughters of bulls with extreme proofs for functional herd life was 1.7 lactations. Quebec dairymen use classification f

    Valor econômico para componentes do leite no estado do Rio Grande do Sul

    No full text
    Com o objetivo de estudar a influência do fator econômico sobre os objetivos de seleção dos animais, foram utilizados dados de produção de um programa de pagamento por qualidade de leite implantado por uma empresa laticinista do estado do Rio Grande do Sul. Os critérios de qualidade do referido programa constavam de teores mínimos de 3,1% de gordura, 2,85% de proteína e no máximo 500.000 unidades de células somáticas. Os dados foram estratificados em três níveis, de acordo com o volume de leite entregue, mensalmente, para a indústria, em função de diferenças significativas em relação aos custos de produção, por litro de leite, decorrentes da escala de produção das propriedades. No nível 1, foram agrupadas as produções das propriedades que entregavam até 1.500 litros de leite/mês, no nível 2, as produções entre 1.501 e 3.000 litros de leite/mês e no nível 3, as produções acima de 3.000 litros de leite/mês. As receitas dos componentes por litro de leite variaram em função da bonificação pelo volume de leite entregue, obtendo maiores valores quanto maior o volume. As despesas definiram o valor econômico para os componentes do leite, em que os custos de produção nos diferentes níveis geraram diferentes funções de lucro. Os valores econômicos (R$) para os componentes foram de -0,4290; -0,1906 e -0,3772 e de -0,0624; 0,0836 e -0,0193 para a gordura e a proteína, respectivamente, nos níveis 1, 2 e 3. O veículo apresentou valor econômico sempre positivo e mais alto que os outros componentes, 0,1964; 0,2093 e 0,2210 para os níveis 1, 2 e 3, respectivamente
    corecore